North America IVD Devices Contract Manufacturing Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The North America IVD Devices Contract Manufacturing Market size is expected to reach US$ 24,408.5 Million by 2034 from US$ 8,514.6 Million in 2025. The market is estimated to record a CAGR of 12.5% from 2026 to 2034.

Executive Summary and North America IVD Devices Contract Manufacturing Market Analysis:

In North America, the IVD devices contract manufacturing market is segmented into the US, Canada, and Mexico. The market is characterized by advanced healthcare infrastructure and high healthcare expenditure, fostering collaborations between diagnostic developers and contract manufacturers. This region emphasizes molecular and immunoassay diagnostics, with strategic partnerships enhancing production efficiency. For example, companies such as Abbott and Roche outsource to specialized firms for point-of-care diagnostics, leveraging robust regulatory frameworks and clinical testing networks to meet growing demand. Statistics show that ~3.3 billion in-vitro diagnostic tests are performed annually in the US, underscoring the need for scalable manufacturing. The shift from in-house to contract manufacturing is driven by increasing costs, encouraging OEMs to adopt outsourcing for cost-cutting measures. Trends include the integration of automation and AI for quality control, with robotics transforming assembly lines for devices such as glucose monitors and PCR platforms. In the US and Canada, biomanufacturing ecosystems support high-value applications, such as companion diagnostics for oncology. Government initiatives, including funding for diagnostic centers, propel innovation. Contract manufacturers provide end-to-end services, from reagent formulation to assembly, allowing OEMs to focus on research and development. This agility addresses chronic disorders and early diagnostics, with over 6,500 medical device companies in the US contributing to a dynamic landscape. Emerging trends, such as home-based testing post-pandemic, have increased outsourcing for rapid kits, ensuring compliance with FDA standards. Overall, North America's focus on precision medicine and technological advancements positions it as a leader in efficient, high-quality IVD production, supporting preventive healthcare and patient outcomes through reliable, innovative diagnostics.

North America IVD Devices Contract Manufacturing Market: Strategic Insights

North America IVD Devices Contract Manufacturing Market Segmentation Analysis:

• By Service Type, the North America IVD Devices Contract Manufacturing Market is segmented into Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services. The Full-device Manufacturing segment dominated the market in 2025.
• By Device Type, the North America IVD Devices Contract Manufacturing Market is segmented into IVD Consumables and IVD Equipment. The IVD Consumables segment dominated the market in 2025.

North America IVD Devices Contract Manufacturing Market Players Density: Understanding Its Impact on Business Dynamics

The North America IVD Devices Contract Manufacturing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America IVD Devices Contract Manufacturing Market Outlook

The prevalence of chronic and infectious diseases, creating the demand for diagnostic tools and prompting original equipment manufacturers (OEMs) to outsource production to meet surging needs, is surging globally. Noncommunicable diseases (NCDs), including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, lead to the death of more than 40 million people each year. Cardiovascular diseases remain the leading cause, followed by cancers, chronic respiratory diseases, and diabetes. The prevalence of diabetes has increased, with over 590 million adults affected worldwide in 2025, as per the International Diabetes Federation (IDF), and many cases are undiagnosed, intensifying the need for reliable testing devices such as blood glucose monitors and point-of-care kits. This growing burden strains in-house manufacturing capacities, leading OEMs to rely on contract manufacturers for scalable, high-volume production. The increased outsourcing of point-of-care diabetes and cardiovascular testing kits, where contract partners manage complex assembly, reagent integration, and quality assurance, enabling OEMs to prioritize innovation and rapid distribution. Outsourcing also supports compliance with stringent regulatory standards while accelerating device availability in high-burden regions, particularly low- and middle-income countries where the majority of premature NCD deaths occur. This driver aligns with global health initiatives aimed at early detection and management, propelling the shift toward specialized contract manufacturing to handle the expanding volume of diagnostic demands efficiently.

North America IVD Devices Contract Manufacturing Market Country Insights

By country, the North America IVD Devices Contract Manufacturing Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2025.

The US IVD devices contract manufacturing landscape is characterized by advanced technological capabilities, robust regulatory oversight, and a focus on innovation to meet the demands of precision diagnostics. The Food and Drug Administration (FDA) provides comprehensive guidance for IVD device studies, emphasizing safety, efficacy, and compliance in clinical investigations, as outlined in the 2010 guidance document that supersedes earlier versions. This framework facilitates outsourcing to contract manufacturers who specialize in cGMP-compliant production, enabling IVD developers to accelerate time-to-market while adhering to quality standards.

Prominent examples include Beckman Coulter's RESOURCE Contract Manufacturing Services, which produce made-to-specification antibody cocktails using antibodies from various sources, manufactured in cGMP facilities to minimize pipetting, QC steps, and reagent waste for flow cytometry applications. BD Biosciences offers contract manufacturing of multicolor panels in liquid, lyophilized, or dried formats, supporting companion diagnostics with over 45 years of flow cytometry expertise and US FDA 21 CFR Part 11-compliant capabilities. Argonaut Manufacturing Services, an FDA-registered CDMO, provides custom formulation and fill-finish for IVD reagents, ensuring scalability from clinical to commercial stages. Statistics reveal that ~3.3 billion IVD tests are conducted annually across 12,000 laboratories in the US, underscoring the high volume driving contract manufacturing needs. Trends include a shift toward automated, ready-to-use reagents and integration of AI for data analysis, as seen in platforms such as Simoa for ultrasensitive biomarker detection with less than 10% CVs in multi-center studies. Additionally, the emphasis on companion diagnostics has led to over 60 million IVD tests sold globally by leaders such as BD, with US-based production playing a key role. Outsourcing helps mitigate costs associated with in-house manufacturing, such as clinical trial batch production averaging 3,000 vials for oncology IVDs.

North America IVD Devices Contract Manufacturing Market Company Profiles

Some of the key players operating in the market include TE Connectivity Ltd, Jabil Inc, Nova Biomedical Corporation, Flex Ltd, Celestica Inc, Fujirebio Europe NV, Thermo Fisher Scientific Inc., Nemera, SMC Ltd, and HiArc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America IVD Devices Contract Manufacturing Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise